Skip to main content
Erschienen in: Reactions Weekly 1/2016

01.10.2016 | Case report

Insulin-lispro

Type I hypersensitivity with hypereosinophilia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Hirai H, et al. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: A case report. Journal of Medical Case Reports 10: No. 202, 25 Jul 2016. Available from: URL: http://doi.org/10.1186/s13256-016-0994-4 - Japan Hirai H, et al. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: A case report. Journal of Medical Case Reports 10: No. 202, 25 Jul 2016. Available from: URL: http://​doi.​org/​10.​1186/​s13256-016-0994-4 - Japan
Metadaten
Titel
Insulin-lispro
Type I hypersensitivity with hypereosinophilia: case report
Publikationsdatum
01.10.2016
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-016-21697-x

Weitere Artikel der Ausgabe 1/2016

Reactions Weekly 1/2016 Zur Ausgabe

Case report

Rituximab

Case report

Antineoplastics

Case report

Cetirizine